Oncology & Cancer

Review dives deep into probiotics for colorectal cancer

Colorectal cancer (CRC) is expected to contribute to a burden of 3.2 million new cases and 1.6 million deaths by 2040. CRC prevention strategies target lifestyle changes, screening high-risk individuals, and polyp removal, ...

Oncology & Cancer

Promising results for a new bowel cancer treatment

A new tablet treatment called divarasib has shown it is very effective in treating a challenging type of bowel (colorectal) cancer associated with the KRAS G12C mutation.

Health

Debunking the top myths about lung cancer screening

Lung cancer is the leading cause of cancer deaths in the U.S., claiming more lives than prostate cancer, breast cancer, and colorectal cancer combined. However, it can be a curable disease if detected early through screening, ...

Gastroenterology

Q&A: Blood tests as an alternative to colonoscopy

Colorectal cancer is the second leading cause of cancer death in the United States. It's also one of the most preventable cancers due to the availability of robust screening tools. Yet nearly 40% of Americans opt out of such ...

Oncology & Cancer

Type 2 diabetes linked to increased risk for colorectal cancer

Type 2 diabetes is associated with an increased risk for colorectal cancer (CRC), with increased associations for those without colonoscopy screening and with smoking history, according to a study published online Nov. 14 ...

page 8 from 40